D'Antoni ML, Boopathy AV, Andreatta K, Chang S, et al. HIV-1 Resistance Analysis of Participants With HIV-1 and Hepatitis B Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide or Dolutegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate Through the Open-Label Extension of the ALLIANCE Study. J Acquir Immune Defic Syndr 2025 Aug 26. doi: 10.1097/QAI.0000000000003749.
PMID: 40857111